Literature DB >> 3770355

Production of histological changes mimicking primary biliary cirrhosis in rabbits by immunization with bile duct antigen.

S Seki, T Matsui, S Nakajima, K Kawai, T Monna, S Yamamoto.   

Abstract

Histopathological liver changes resembling primary biliary cirrhosis were induced in an experimental animal model. A special strain of rabbit received an antigen prepared from scrapings of bovine gallbladder mucosa. Eventually, 47 out of 84 antigen-treated rabbits displayed histopathological liver features resembling those of chronic non-suppurative destructive cholangitis as seen in humans. In addition, granuloma formation, ductular proliferation and fibrosis were seen in some cases. However, advanced lesions consistent with micronodular cirrhosis have not been found. Lymphocytes seemed to play an important role triggering early pathogenetic mechanisms, judging from the presence of lymphocytes invading the basement membrane of the affected bile ducts. Furthermore, we observed by electron microscopy that the epithelial cells of the involved bile ducts revealed both mitochondrial swelling and dilatation of endoplasmic reticulum cisternae. In summary, our experimental animal model offers interesting possibilities regarding the study of pathogenesis and development of primary biliary cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3770355     DOI: 10.1007/bf02774132

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  10 in total

1.  PRIMARY BILIARY CIRRHOSIS. CHRONIC NON-SUPPURATIVE DESTRUCTIVE CHOLANGITIS.

Authors:  E RUBIN; F SCHAFFNER; H POPPER
Journal:  Am J Pathol       Date:  1965-03       Impact factor: 4.307

2.  Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis).

Authors:  J Ludwig; E R Dickson; G S McDonald
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1978-08-22

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Ultrastructural aspects of primary biliary cirrhosis and other types of cholestatic liver disease.

Authors:  A Chedid; M A Spellberg; R A DeBeer
Journal:  Gastroenterology       Date:  1974-11       Impact factor: 22.682

5.  Experimental production of cholangitis by 1,4-phenylenediisothiocyanate.

Authors:  H Selye; S Szabo
Journal:  Arch Pathol       Date:  1972-12

6.  Electron microscopy of liver lesions in primary biliary cirrhosis. II. A bile duct with chronic non-suppurative destructive cholangitis.

Authors:  K Tobe
Journal:  Acta Pathol Jpn       Date:  1982-03

7.  Experimental chronic non-suppurative destructive cholangitis in rabbits following immunization with bile duct antigen.

Authors:  K Kawai; H Kitagawa; T Higashimori; T Matsui; S Fujiyama; T Monna; S Yamamoto; S Morisawa
Journal:  Gastroenterol Jpn       Date:  1980

8.  Spontaneous "primary biliary cirrhosis" in rabbits.

Authors:  V Tison; F Callea; C Morisi; A M Mancini; V J Desmet
Journal:  Liver       Date:  1982-06

9.  Is primary biliary cirrhosis an immune complex disease?

Authors:  H C Thomas; B J Potter; S Sherlock
Journal:  Lancet       Date:  1977-12-17       Impact factor: 79.321

10.  Ultrastructural lesions of bile ducts in primary biliary cirrhosis. A comparison with the lesions observed in graft versus host disease.

Authors:  D Bernuau; G Feldmann; C Degott; C Gisselbrecht
Journal:  Hum Pathol       Date:  1981-09       Impact factor: 3.466

  10 in total
  2 in total

1.  Simultaneous production of hepatic lesions and circulating antimitochondrial antibody in an experimental animal model of primary biliary cirrhosis.

Authors:  M Yamashiki; Y Kosaka; S Sakaguchi; F Ichida
Journal:  Gastroenterol Jpn       Date:  1990-02

2.  Generation of biliary lesions after transfer of human lymphocytes into severe combined immunodeficient (SCID) mice.

Authors:  S M Krams; K Dorshkind; M E Gershwin
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.